X-Chem Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
182
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
6
- Investments
-
3
X-Chem General Information
Description
Provider of biotechnological services in Waltham, Massachusetts. The company's biotechnological services include drug discovery generated by iterative combinatorial synthesis of small molecules tethered to DNA tags that record the synthetic history of the small molecule.
Contact Information
Website
www.x-chemrx.comCorporate Office
- 100 Beaver Street
- Suite 101
- Waltham, MA 02453
- United States
Corporate Office
- 100 Beaver Street
- Suite 101
- Waltham, MA 02453
- United States
X-Chem Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
X-Chem Comparisons
Industry
Financing
Details
X-Chem Competitors (28)
One of X-Chem’s 28 competitors is Editas Medicine, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Editas Medicine | Formerly VC-backed | Cambridge, MA | ||||
| Domainex | Venture Capital-Backed | Saffron Walden, United Kingdom | ||||
| PhenoVista Biosciences | Venture Capital-Backed | San Diego, CA | ||||
| Active Biotech | Corporation | Lund, Sweden | ||||
| A-Alpha Bio | Venture Capital-Backed | Seattle, WA |
X-Chem Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
X-Chem Patents
X-Chem Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230357308-A1 | Crystalline sodium cholesteryl sulfonate | Inactive | 12-Oct-2020 | ||
| US-20230365618-A1 | Crystalline thiocholesterol | Inactive | 12-Oct-2020 | ||
| US-20230056273-A1 | Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for preparing same | Pending | 27-Dec-2019 | ||
| EP-4004202-A1 | Methods for tagging and encoding of pre-existing compound libraries | Inactive | 25-Jul-2019 | ||
| US-20220275362-A1 | Methods for tagging and encoding of pre-existing compound libraries | Inactive | 25-Jul-2019 | C12N15/1065 |
X-Chem Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
X-Chem Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
X-Chem Investments (3)
X-Chem’s most recent deal was a Buyout/LBO with Glamorous AI. The deal was made on 28-Oct-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Glamorous AI | 28-Oct-2021 | Buyout/LBO | Discovery Tools (Healthcare) | ||
| ComInnex | 25-Oct-2021 | Buyout/LBO | BPO/Outsource Services | ||
| IntelliSyn Pharma | 26-Jan-2021 | Buyout/LBO | BPO/Outsource Services |
X-Chem FAQs
-
When was X-Chem founded?
X-Chem was founded in 2009.
-
Where is X-Chem headquartered?
X-Chem is headquartered in Waltham, MA.
-
What is the size of X-Chem?
X-Chem has 182 total employees.
-
What industry is X-Chem in?
X-Chem’s primary industry is Drug Discovery.
-
Is X-Chem a private or public company?
X-Chem is a Private company.
-
What is X-Chem’s current revenue?
The current revenue for X-Chem is .
-
How much funding has X-Chem raised over time?
X-Chem has raised $28M.
-
Who are X-Chem’s investors?
GHO Capital has invested in X-Chem.
-
Who are X-Chem’s competitors?
Editas Medicine, Domainex, PhenoVista Biosciences, Active Biotech, and A-Alpha Bio are some of the 28 competitors of X-Chem.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
